Qsymia
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.qsymia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Qsymia
Qsymia is a prescription medication that combines phentermine and topiramate in an extended-release form, designed for weight management in adults and children aged 12-17. The product is clinically proven to aid in weight loss when used alongside a healthy diet and regular exercise. It is offered with multiple savings options to assist patients in accessing the medication. Qsymia aims to provide a convenient, once-daily oral solution for individuals looking to achieve their weight-management goals.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Qsymia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Qsymia had a recent Job posting/layoffs
Qsymia, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Qsymia recently announced quarterly report
Product Launch: Get notified when Qsymia launches new products
Funding: Get notified immidiatlly once Qsymia has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Qsymia
Check out if Qsymia is spiking on competitors!
Check if Qsymia has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Qsymia
Find more new buyers
Compare Similar Companies to Qsymia
Compare insights from companies similar to Qsymia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Qsymia
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Qsymia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Qsymia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Qsymia.
Qsymia Tech Stack
A closer look at the technologies used by Qsymia
Qsymia News & Media
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 44th Annual J.P. Morgan Healthcare Conference
CAMPBELL, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, today announced it will provide updates to its pipeline and key program milestones during the 44th Annual J.P. Morgan Healthcare Conference 2026.VIVUS Introduces Lower Pricing on QSYMIA® at Costco Locations Across Hawaii
— Through this program, QSYMIA will be available for less than $2.33 a day/$69 a month at participating Costco Pharmacies in Hawaii — Through this program, QSYMIA will be available for less than $2.33 a day/$69 a month at participating Costco Pharmacies in HawaiiVIVUS Announces QSYMIA® Price Reduction at Costco Pharmacies Nationwide
— Lowered price at retail pharmacy to expand access to overweight or obesity treatment to more patientsVIVUS Showcases Leadership in Obesity Management at the 2025 International Congress on Obesity and MEtabolic Syndrome (ICOMES)
— Presentations spotlight VIVUS’s 13-year track record of leadership with QSYMIA® (phentermine and topiramate extended-release capsules CIV) in the treatment of obesity and overweight
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Qsymia
Sign Up For FreeTo access detailed company insights
Qsymia is a prescription medication that combines phentermine and topiramate in an extended-release form, designed for weight management in adults and children aged 12-17. The product is clinically proven to aid in weight loss when used alongside a healthy diet and regular exercise. It is offered with multiple savings options to assist patients in... Read More
